Published in J Am Heart Assoc on October 25, 2012
Coronary artery spasm as a cause of angina. Circulation (2014) 1.18
Coronary flow reserve from mouse to man--from mechanistic understanding to future interventions. J Cardiovasc Transl Res (2013) 0.84
Diagnosis of coronary microvascular dysfunction - Present status. Indian Heart J (2015) 0.76
Current Diagnostic and Therapeutic Strategies in Microvascular Angina. Curr Emerg Hosp Med Rep (2015) 0.75
Determinants of Myocardial Lactate Production During Acetylcholine Provocation Test in Patients With Coronary Spasm. J Am Heart Assoc (2015) 0.75
Etiopathogenesis of microvascular angina: caveats in our knowledge. Indian Heart J (2014) 0.75
Late gadolinium enhancement on cardiac magnetic resonance predicts coronary vasomotor abnormality and myocardial lactate production in patients with chronic heart failure. Heart Vessels (2016) 0.75
CYP2C19 variants and epoxyeicosatrienoic acids in patients with microvascular angina. Int J Cardiol Heart Vasc (2017) 0.75
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics (1988) 70.41
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr (2005) 46.32
Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation (2007) 20.44
Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis (2009) 18.60
The electrocardiogram in population studies. A classification system. Circulation (1960) 11.86
Universal definition of myocardial infarction. Circulation (2007) 11.69
Low diagnostic yield of elective coronary angiography. N Engl J Med (2010) 9.38
Angina pectoris. I. A variant form of angina pectoris; preliminary report. Am J Med (1959) 8.04
Coronary microvascular dysfunction. N Engl J Med (2007) 5.22
Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation (2007) 4.58
Angina pectoris caused by coronary microvascular spasm. Lancet (1998) 3.01
Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation (1992) 2.88
Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. J Am Coll Cardiol (2010) 2.68
Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation (1985) 2.61
Microvascular angina and the continuing dilemma of chest pain with normal coronary angiograms. J Am Coll Cardiol (2009) 2.58
Coronary artery spasm as a frequent cause of acute coronary syndrome: The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study. J Am Coll Cardiol (2008) 2.48
Coronary artery spasm--clinical features, diagnosis, pathogenesis, and treatment. J Cardiol (2008) 2.27
Persistent chest pain and no obstructive coronary artery disease. JAMA (2009) 2.27
High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). J Am Coll Cardiol (2012) 2.24
Digital assessment of endothelial function and ischemic heart disease in women. J Am Coll Cardiol (2010) 2.12
Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation (2010) 2.03
Long-term prognosis for patients with variant angina and influential factors. Circulation (1988) 1.64
Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2008): digest version. Circ J (2010) 1.63
Three-year follow-up of the Japanese patients with microvascular angina attributable to coronary microvascular spasm. Int J Cardiol (2001) 1.43
Microvascular coronary dysfunction in women: pathophysiology, diagnosis, and management. Curr Probl Cardiol (2011) 1.08
Myocardial lactate and pyruvate metabolism. J Clin Invest (1962) 1.07
Nitric oxide-mediated flow-dependent dilation is impaired in coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol (1997) 1.00
Syndrome X and microvascular coronary dysfunction. Circulation (2011) 0.97
Coronary hemodynamic and myocardial metabolic alterations accompanying coronary spasm. Am J Cardiol (1979) 0.85
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet (2010) 13.13
The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol (2010) 6.95
Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA (2008) 6.15
Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med (2011) 4.81
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. N Engl J Med (2011) 3.20
Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: the PRASFIT-ACS study. Circ J (2014) 2.76
Prognostic stratification of patients with vasospastic angina: a comprehensive clinical risk score developed by the Japanese Coronary Spasm Association. J Am Coll Cardiol (2013) 2.51
Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis. Arterioscler Thromb Vasc Biol (2004) 2.46
Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors. Cancer Res (2012) 2.45
Interpretation of and preference for probability expressions among Japanese patients and physicians. Fam Pract (2002) 2.43
Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment. Dig Endosc (2013) 2.30
A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice. J Am Coll Cardiol (2012) 2.23
Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction. J Am Coll Cardiol (2012) 2.19
Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab (2009) 2.13
Digital assessment of endothelial function and ischemic heart disease in women. J Am Coll Cardiol (2010) 2.12
A novel pit pattern identifies the precursor of colorectal cancer derived from sessile serrated adenoma. Am J Gastroenterol (2012) 2.06
Reactivity of the human internal thoracic artery to vasodilators in coronary artery bypass grafting. Eur J Cardiothorac Surg (2004) 2.05
Effects of endothelial dysfunction on residual platelet aggregability after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. Circ Cardiovasc Interv (2013) 2.00
Analysis of oxidative stress expressed by urinary level of 8-hydroxy-2'-deoxyguanosine and biopyrrin in atrial fibrillation: effect of sinus rhythm restoration. Int J Cardiol (2012) 1.97
The dynamic nature of coronary artery lesion morphology assessed by serial virtual histology intravascular ultrasound tissue characterization. J Am Coll Cardiol (2010) 1.90
Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease. J Am Coll Cardiol (2006) 1.84
Quantitative evaluation of the diagnostic thinking process in medical students. J Gen Intern Med (2002) 1.82
Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction. Am J Pathol (2004) 1.79
Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients. Am J Med (2012) 1.76
Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease. Eur Heart J (2010) 1.74
Right ventricular reverse remodelling after balloon pulmonary angioplasty. Eur Respir J (2014) 1.73
Echolucent carotid plaques predict future coronary events in patients with coronary artery disease. J Am Coll Cardiol (2004) 1.71
Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan. Am J Med (2004) 1.70
DNA methylation and microRNA dysregulation in cancer. Mol Oncol (2012) 1.69
Clinical implications of provocation tests for coronary artery spasm: safety, arrhythmic complications, and prognostic impact: multicentre registry study of the Japanese Coronary Spasm Association. Eur Heart J (2012) 1.68
Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartan. Hypertension (2007) 1.68
Ischemic intestinal involvement in a patient with Buerger disease: case report and literature review. J Vasc Surg (2003) 1.67
Coronary microvascular dysfunction and diastolic load correlate with cardiac troponin T release measured by a highly sensitive assay in patients with nonischemic heart failure. J Am Coll Cardiol (2013) 1.59